pharma
Swallowable capsules could revolutionise bowel disorder treatment
January 9, 2018Research and Development biotech, drugs, pharma, pharmaceutical
Researchers from RMIT University in Australia were tasked with developing a more effective breath test for determining what was happening …
Sri Lanka to build first-ever pharmaceutical manufacturing zone
January 9, 2018Manufacturing and Production Pharma Zone, Sri Lanka, manufacturing, pharma
Sri Lanka is set to build its first-ever exclusive pharmaceutical manufacturing zone, it has emerged. The State Pharmaceuticals Manufacturing Corporation …
Six-strong collaboration to sequence 500,000 exomes
January 9, 2018Manufacturing and Production, Research and Development UK Biobank, biotech, drugs, pharma, pharmaceutical
A collaboration that sees six pharma players come together to fund the sequencing of a particular section of DNA of …
Shire announces split into two business units, downgrades revenue forecast
January 9, 2018Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease
Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …
Hunt resists move from health secretary position, receives expanded role
January 9, 2018Manufacturing and Production, Medical Communications Jeremy Hunt, NHS, Theresa May, biotech, drugs, pharma, pharmaceutical
As part of Theresa May’s well-publicised cabinet reshuffle, many were expecting Jeremy Hunt to move from his position as Secretary …
Axovant’s drug bested by placebo, shares reduced to dust
January 8, 2018Manufacturing and Production, Research and Development Axovant, Roivant, biotech, dementia, drugs, pharma, pharmaceutical
The signs were already there for Axovant Sciences’ key drug, intepirdine, when it posted poor results from a recent study …
Sanofi and Alynylam rejig sees global rights switch-up
January 8, 2018Sales and Marketing Alynylam, Sanofi, biotech, drugs, pharma, pharmaceutical
The Sanofi-Alynylam alliance has been in place since 2014, with the latest development seeing the two companies each take their …
The PROs and cons of pushing patient centricity
January 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient reported outcomes, pharma
As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how …
FDA clears Amgen’s bone drug for multiple myeloma
January 8, 2018Sales and Marketing Amgen, Cancer, Xgeva, multiple myeloma, pharma
Amgen has announced that the FDA has approved the indication expansion of its drug Xgeva (denosumab) to include the treatment …
Celgene in $7bn shot on Impact
January 8, 2018Sales and Marketing Celgene, Impact Biomedicines, biotech, drugs, pharma, pharmaceutical
Billions of dollars do not often get put down for drugs that have been dropped by a major pharma company, …
Novo Nordisk ups acquisition bid to €2.6 billion, Ablynx says no
January 8, 2018Sales and Marketing Ablynx, Novo Nordisk, acquisition, pharma
It has emerged that Novo Nordisk has extended a bid of €2.6 billion to buy Belgian biotech Ablynx. The new …
Pfizer exits neuroscience R&D space
January 8, 2018Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer announced over the weekend that it would be backing out of research and development into the neuroscience area, abandoning …
Philippines’ FDA suspends Dengvaxia marketing, Sanofi responds
January 5, 2018Medical Communications, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
As the Dengvaxia scandal in the Philippines rolls into 2018, it emerges that the country’s Food and Drugs Administration has …
Novartis Pharma Ex-CEO takes three roles in two days
January 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Epstein, Flagship Pioneering, biotech, drugs, pharma, pharmaceutical
Former CEO of Novartis Pharmaceuticals, David Epstein, has had a busy start to the year, accepting not one but three …
Takeda agrees $630m takeover of TiGenix
January 5, 2018Medical Communications, Sales and Marketing Takeda, TiGenix, biotech, drugs, pharma, pharmaceutical
Takeda already had a strong working relationship with TiGenix, after previously signing a licensing agreement with the Belgium-based pharma company …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
